Form 4 for GH Guardant Health, Inc.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001576280-25-000175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-16 | 2025-06-12 | GH | Krognes Steve E. | Dir | M - OptEx | $0.00 | +6,674 | 17.7K | +61% | $0 |
| D | 2025-06-16 | 2025-06-12 | GH | Krognes Steve E. | Dir | M - OptEx | $0.00 | -6,674 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | M | A | 6,674 | $0.00 | 17,665 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-06-12 | M | D | 6,674 | $0.00 | 0 | D | $0.00 · — to — | 6,674 Common Stock | (F1) The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. (F2) Not applicable for Restricted Stock Units. |